table of content
1 Introduction to Research & Analysis Reports
1.1 Non-Invasive Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Invasive Cancer Diagnostics Overall Market Size
2.1 Global Non-Invasive Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Non-Invasive Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Invasive Cancer Diagnostics Players in Global Market
3.2 Top Global Non-Invasive Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Non-Invasive Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Non-Invasive Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Invasive Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Non-Invasive Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Invasive Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Invasive Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 CTCs
4.1.3 CTNAS
4.1.4 Exosomes
4.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Non-Invasive Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Invasive Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Blood
5.1.3 Urine
5.1.4 Saliva
5.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Non-Invasive Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Non-Invasive Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Non-Invasive Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Non-Invasive Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Non-Invasive Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Non-Invasive Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Non-Invasive Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Non-Invasive Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Invasive Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Non-Invasive Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Non-Invasive Cancer Diagnostics Market Size, 2018-2029
7 Non-Invasive Cancer Diagnostics Companies Profiles
7.1 Gen-Probe Inc
7.1.1 Gen-Probe Inc Company Summary
7.1.2 Gen-Probe Inc Business Overview
7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Gen-Probe Inc Key News & Latest Developments
7.2 Digene Corporation
7.2.1 Digene Corporation Company Summary
7.2.2 Digene Corporation Business Overview
7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Digene Corporation Key News & Latest Developments
7.3 Quest Diagnostics Inc
7.3.1 Quest Diagnostics Inc Company Summary
7.3.2 Quest Diagnostics Inc Business Overview
7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Quest Diagnostics Inc Key News & Latest Developments
7.4 Cancer, Genetics Inc
7.4.1 Cancer, Genetics Inc Company Summary
7.4.2 Cancer, Genetics Inc Business Overview
7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Cancer, Genetics Inc Key News & Latest Developments
7.5 BIOVIEW Inc
7.5.1 BIOVIEW Inc Company Summary
7.5.2 BIOVIEW Inc Business Overview
7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 BIOVIEW Inc Key News & Latest Developments
7.6 AVIVA Biosciences Corporation
7.6.1 AVIVA Biosciences Corporation Company Summary
7.6.2 AVIVA Biosciences Corporation Business Overview
7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Major Product Offerings
7.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 AVIVA Biosciences Corporation Key News & Latest Developments
7.7 Laboratory Corporation of America Holdings (LabCorp)
7.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Summary
7.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Major Product Offerings
7.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Laboratory Corporation of America Holdings (LabCorp) Key News & Latest Developments
7.8 A&G Pharmaceutical
7.8.1 A&G Pharmaceutical Company Summary
7.8.2 A&G Pharmaceutical Business Overview
7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Major Product Offerings
7.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 A&G Pharmaceutical Key News & Latest Developments
7.9 Affymetrix Inc
7.9.1 Affymetrix Inc Company Summary
7.9.2 Affymetrix Inc Business Overview
7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Major Product Offerings
7.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Affymetrix Inc Key News & Latest Developments
7.10 Precision Therapeutics
7.10.1 Precision Therapeutics Company Summary
7.10.2 Precision Therapeutics Business Overview
7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Major Product Offerings
7.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Precision Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
